Isoflurane enhances the expression of circ_0088233 to promote the malignancy of prostate cancer through circ_0088233-mediated miR-33b-5p/HIF1A pathway

Author:

Rong Lu1,Xue Huanzhou1,Hao Jianwei1,Liu Jianjun1,Xu Hao1

Affiliation:

1. People’s Hospital of Zhengzhou University, Henan Provincial People’s Hospital

Abstract

Abstract Background The effects of isoflurane (Iso) on the viability and migration of cancer cells is crucial for the use of Iso in tumor resection. The objective of this study was to evaluate the effect of Iso on the function of prostate cancer (PCa) in cell proliferation, survival and migration, and to explore the potential mechanism of isoflurane action from the perspective of circular RNA (circRNA). Methods The effects of Iso on cell viability, cell apoptosis, cell invasion and cell migration were determined by cell counting kit-8 (CCK-8), flow cytometry, transwell and wound healing assays, respectively. The expression of circ_0088233, microRNA-33b-5p (miR-33b-5p) and hypoxia inducible factor 1 subunit alpha (HIF1A) was detected by quantitative real-time PCR (qPCR). The underlying relationship between miR-33b-5p and circ_0088233 or HIF1A was verified by dual-luciferase reporter assay and RNA pull-down assay. Animal study was conducted to determine the effects of Iso in vivo. Results Iso enhanced PCa cell viability, invasion and migration and inhibited cell apoptosis. Iso promoted the expression of circ_0088233, and circ_0088233 knockdown partly abolished the effects of Iso and thus inhibited PCa cell malignant behaviors. MiR-33b-5p was a target of circ_0088233, and HIF1A was a target of miR-33b-5p. Circ_0088233 knockdown inhibited PCa cell malignant behaviors by enriching miR-33b-5p, and miR-33b-5p restoration inhibited PCa cell malignant behaviors by sequestering HIF1A. Iso contributed to tumor growth in vivo by increasing circ_0088233 expression. Conclusion Iso strengthened the expression of circ_0088233 to promote the malignant development of PCa through circ_0088233-mediated miR-33b-5p/HIF1A pathway.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3